German regulator denies GMP nod to DRLs Bachupally Unit 2

Published On 2017-08-13 04:45 GMT | Update On 2017-08-13 04:45 GMT

New Delhi: Drug firm Dr Reddy's Laboratories (DRL) said the German regulator has not renewed good manufacturing practice (GMP) compliance certificate of its formulations facility 2 in Bachupally in Hyderabad.

The communication came after a recent inspection of the plant, Dr Reddy's Laboratories said in a filing to BSE.

Betapharm Arzneimittel GmbH, Germany, the company's wholly-owned arm received a communication "from the regulatory authority of Germany (Regierung von Oberbayern) last night, that the GMP compliance certificate in respect of company's formulations manufacturing Unit 2 plant in Bachupally, Hyderabad, is not renewed consequent to the recent inspection of the plant", it added.

Pending revocation of the non-compliance notification, the plant will not be able to make any further exports to the European Union until the next inspection, Dr Reddy's said.

The inspection is to be initiated by an invitation from Betapharm, it added.

Article Source : PTI

Disclaimer: This site is primarily intended for healthcare professionals. Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription. Use of this site is subject to our terms of use, privacy policy, advertisement policy. © 2020 Minerva Medical Treatment Pvt Ltd

Comments Policy

Our comments section is governed by our Comments Policy . By posting comments at Medical Dialogues you automatically agree with our Comments Policy , Terms And Conditions and Privacy Policy .

German regulator denies GMP nod to DRLs Bachupally Unit 2

Similar News